As previously stated, PI3K downstream signaling pathways may be altered in XLP-1 patients, thus we evaluated the expression of PI3K subunits p110δ and p85α, as well as downstream key proteins including AKT, p-AKT and mTOR in both the proband and the parents. This evidence concerns the gene MTOR and X-linked lymphoproliferative syndrome.